When AI and RWE Converge: Accelerating Evidence for Rare Disease and Innovative Therapies
Why Evidence for Rare Disease Matters AI and real-world evidence (RWE) are reshaping the path from laboratory discovery to regulatory approval. Their convergence matters most for patients who can’t…
Read the full articleYou might also wanna read
AI and RWE: A New Era for Rare Disease Treatment
AI and real-world evidence (RWE) are revolutionizing rare disease therapies. By integrating data from diverse sources, AI accelerates treatm
Promise to Practice: Reimagining Artificial Intelligence for Equitable Global Health Impact
Artificial Intelligence (AI) is transforming health worldwide, yet its benefits remain unevenly distributed and insufficiently evaluated in
How AI Is Modernizing Clinical Trial Protocols for Smarter Drug Development
By fine-tuning domain-specific models with real clinical operations data — such as historical performance, feasibility outcomes, enrollment
medcitynews.com·1mo agoGetting AI to Stick to Our Hippocratic Oath
News about AI in healthcare is everywhere — as a scribe to help with billing and the EHR; as a way to get a second opinion on difficult case
AI model helps diagnose rare diseases in patients after years of uncertainty, study finds
The team hopes its models can help patients get diagnoses for rare diseases.
abcnews.com·25d agoArtificial intelligence (AI) in action: a cross-continental survey of AI adoption among field epidemiology fellows in Canada, the United States, and Europe, 2024
BACKGROUND Technologies available for applied public health practice are rapidly evolving. Artificial intelligence (AI) tools have become mo
Comments
Sign in to join the conversation.
No comments yet. Be the first.